Best GLP-1 Telehealth Providers in Boston, MA

Telehealth platform specializing in affordable compounded GLP-1 medications for weight loss. Known for aggressive pricing on compounded semaglutide and tirzepatide with fast onboarding.

Major telehealth platform offering GLP-1 weight loss programs with compounded and brand-name semaglutide and tirzepatide. Known for accessible pricing and a streamlined digital experience.

Weight-care platform combining GLP-1 medications with behavior change coaching, nutrition guidance, and community support. Takes a holistic approach beyond medication alone.

Publicly traded (NYSE: HIMS) telehealth company offering GLP-1 weight loss treatments alongside men's and women's health services. Offers both compounded and brand-name GLP-1 options.

Telehealth marketplace connecting patients with licensed doctors for peptide therapy, hormone optimization, and wellness prescriptions. Competitive pricing through network model.

Metabolic health company offering a comprehensive one-year GLP-1 weight loss program that combines medication with metabolic reset through food, sleep, exercise, and emotional health coaching.

Men's health telehealth platform offering hormone optimization and peptide therapy with at-home lab testing and physician-guided treatment plans.

Large-scale telehealth platform (publicly traded) offering weight management via GLP-1 medications alongside dermatology, hair loss, and primary care services.

Integrated telehealth platform with primary care and specialized peptide/weight-loss programs. Appeals to users wanting peptide therapy within a broader healthcare relationship.

FORM Health is a physician-led obesity medicine practice delivered entirely via telehealth. Unlike platforms that added GLP-1 prescribing to an existing product (Noom, Hims, Ro), FORM was built from the ground up as an obesity medicine specialty practice. Every FORM clinician is a board-certified physician specializing in obesity medicine — not general practitioners doing questionnaire reviews. This clinical depth comes at a premium price point, but delivers a level of medical sophistication tha

Noom started as a behavior-change app focused on psychology-driven weight loss coaching, built around cognitive behavioral therapy (CBT) principles. In 2023, they launched Noom Med, adding GLP-1 prescriptions to their platform. This makes Noom one of the few providers that combines medication with a structured behavioral curriculum — an approach that could help address the weight regain problem associated with GLP-1 discontinuation. The coaching program predates the medication offering by over a

PlushCare is a broad-spectrum telehealth platform offering primary care, mental health, dermatology, and weight management — not a weight-loss-specific company. Acquired by Accolade (publicly traded health services company) in 2021, PlushCare brings the backing of an established healthcare organization. Their generalist model means GLP-1 prescriptions happen within a broader healthcare relationship, and they work extensively with insurance rather than pushing cash-pay compounded medications.

Sequence positions itself as the "clinical-first" GLP-1 telehealth provider. Founded by obesity medicine specialists, the platform emphasizes board-certified clinicians, insurance-first prescribing, and a medically rigorous approach compared to most direct-to-consumer competitors. Their model prioritizes getting patients onto brand-name FDA-approved medications through insurance rather than defaulting to compounded alternatives.

Sesame takes a radically different approach to telehealth GLP-1 access: no subscriptions, no memberships, no monthly fees. You pay per visit, get a prescription if appropriate, and fill it wherever you want. Think of Sesame as the à la carte option — stripped-down, transparent pricing with no ongoing commitments. This model gives patients maximum flexibility but shifts the work of finding affordable medication to the patient.